Table 4.
Alaska | Northern Canada | Greenland | |||||||
---|---|---|---|---|---|---|---|---|---|
2000– 2004 N (%) |
2005– 2010 N (%) |
p- value |
2000– 2004 N (%) |
2005– 2010 N (%) |
p- value |
2000– 2004 N (%) |
2005– 2010 N (%) |
p- value |
|
Streptococcus pneumoniae | 35 | 44 | 0.9 | 11 | 14 | 0.9 | 6 | 9 | 0.7 |
PCV7 serotypeb | 11 (31) | 1 (2) | <0.001 | 5 (46) | 2 (14) | 0.1 | 3 (50) | 3 (33) | 0.8 |
PCV6+ serotypec | 5 (14) | 19 (43) | 0.01 | 3 (27) | 3 (21) | 0.7 | 1 (17) | 2 (22) | 0.7 |
Non-PCV serotype | 19 (54) | 24 (55) | 0.9 | 3 (27) | 9 (64) | 0.2 | 2 (33) | 4 (44) | 0.6 |
Haemophilus influenzae | 10 | 15 | 0.7 | 17 | 16 | 0.3 | N/A | N/A | N/A |
Serotype a | 2 (20) | 7 (47) | 0.2 | 11 (65) | 10 (62) | 0.4 | N/A | N/A | N/A |
Serotype b | 4 (40) | 2 (13) | 0.3 | 5 (29) | 3 (19) | 0.3 | N/A | N/A | N/A |
Other serotyped | 4 (40) | 6 (40) | 0.8 | 1 (6) | 3 (19) | 0.5 | N/A | N/A | N/A |
Neisseria meningitidis | 16 | 13 | 0.2 | 3 | 6 | 0.3 | 3 | 2 | 0.5 |
Serogroup A, C, Y, W135 | 3 (19) | 1 (8) | 0.2 | 2 (67) | 2 (33) | 0.8 | 1 (33) | 0 (0) | 0.3 |
Serogroup B | 13 (81) | 12 (92) | 0.4 | 1 (33) | 4 (67) | 0.3 | 2 (67) | 2 (100) | 0.9 |
Other serogroup | 0 (0) | 0 (0) | --- | 0 (0) | 0 (0) | --- | 0 (0) | 0 (0) | --- |
Abbreviations: N/A, data not available; PCV, pneumococcal conjugate vaccine.
Data shown for subset of meningitis cases from whom isolates were available for laboratory serotype/serogroup determination.
Includes the 7 serotypes included in the 7-valent pneumococcal conjugate vaccine (4, 6B, 9V, 14,18C, 19F, 23F).
Includes the 6 additional serotypes included in the 13 -valent pneumococcal conjugate vaccine (1, 3, 5, 6A, 7F, 19A).
Includes non-typeable Haemophilus influenza.